Epstein, S E <br/><br/>
Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects.  [electronic resource] 

 -  Circulation  Jul 2001 
 - 115-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.cir.104.1.115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arteriosclerosis--metabolism<br/>Blood Vessels--drug effects<br/>Capillary Permeability--drug effects<br/>Cardiovascular Diseases--therapy<br/>Chemokine CCL2--pharmacology<br/>Contraindications<br/>Coronary Vessels--drug effects<br/>Diabetic Retinopathy--metabolism<br/>Disease Progression<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Endothelial Growth Factors--adverse effects<br/>Fibroblast Growth Factors--adverse effects<br/>Genetic Vectors--adverse effects<br/>Humans<br/>Hypotension--chemically induced<br/>Lymphokines--adverse effects<br/>Mice<br/>Neoplasms--metabolism<br/>Neovascularization, Physiologic--drug effects<br/>Organ Specificity--drug effects<br/>Proto-Oncogene Proteins--metabolism<br/>Receptor Protein-Tyrosine Kinases--metabolism<br/>Receptors, Growth Factor--metabolism<br/>Receptors, Vascular Endothelial Growth Factor<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factor Receptor-1<br/>Vascular Endothelial Growth Factors<br/>Vasomotor System--drug effects